AAA
Affinity Asset Advisors’s Mineralys Therapeutics MLYS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.2M | Sell |
900,000
-200,000
| -18% | -$2.71M | 1.66% | 18 |
|
|
2025
Q1 | $17.5M | Buy |
1,100,000
+750,000
| +214% | +$11.9M | 1.67% | 12 |
|
|
2024
Q4 | $4.31M | Hold |
350,000
| – | – | 0.58% | 35 |
|
|
2024
Q3 | $4.24M | Buy |
350,000
+22,041
| +7% | +$267K | 0.58% | 44 |
|
|
2024
Q2 | $3.84M | Hold |
327,959
| – | – | 0.44% | 45 |
|
|
2024
Q1 | $4.23M | Buy |
+327,959
| New | +$4.23M | 0.52% | 45 |
|
|
2023
Q3 | – | Sell |
-62,500
| Closed | -$1.07M | – | 80 |
|
|
2023
Q2 | $1.07M | Hold |
62,500
| – | – | 0.37% | 44 |
|
|
2023
Q1 | $979K | Buy |
+62,500
| New | +$979K | 0.32% | 48 |
|